23.76
0.54 (2.33%)
0.54 (2.33%)
Upgrade to Real-Time
Afterhours (Closed)
Low
6.44
High
28.6599
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prothena Corporation PLC | PRTA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.54 | 2.33% | 23.76 | 16:01:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 23.13 | 22.56 | 24.34 | 23.76 | 23.22 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 20.00 | 24.39 | 4.39 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,059 | 128,410 | $ 23.82 | $ 3,058,893 | 247,426 | 6.44 - 28.6599 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:08:08 | priorref | 165 | $ 23.76 | USD |
Prothena Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 948.53M | 39.92M | 30.48M | $ 814.00k | $ - | -1.95 | -5.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Prothena News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRTA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.23 | 25.96 | 22.02 | 24.18 | 210,256 | -0.47 | -1.94% |
| 1 Month | 24.8817 | 28.6599 | 21.55 | 25.00 | 357,329 | -1.12 | -4.51% |
| 3 Months | 12.35 | 28.6599 | 10.72 | 21.50 | 527,279 | 11.41 | 92.39% |
| 6 Months | 12.25 | 28.6599 | 10.72 | 18.29 | 375,477 | 11.51 | 93.96% |
| 1 Year | 9.74 | 28.6599 | 6.44 | 15.24 | 329,399 | 14.02 | 143.94% |
| 3 Years | 13.69 | 28.6599 | 6.44 | 13.17 | 363,516 | 10.07 | 73.56% |
| 5 Years | 47.70 | 70.00 | 6.44 | 27.14 | 361,636 | -23.94 | -50.19% |
Prothena Description
| Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding and inflammatory cell adhesion disorders. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). |
